Want to see HK:6681 full AI Analyst Report?
Total Valuation
BrainAurora Medical Technology Limited has a market cap or net worth of HK$2.04B. The enterprise value is HK$1.81K.
Market CapHK$2.04B
Enterprise ValueHK$1.81K
Share Statistics
BrainAurora Medical Technology Limited has 1,358,278,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,358,278,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BrainAurora Medical Technology Limited’s return on equity (ROE) is -3.23 and return on invested capital (ROIC) is -43.90%.
Return on Equity (ROE)-3.23
Return on Assets (ROA)-0.43
Return on Invested Capital (ROIC)-43.90%
Return on Capital Employed (ROCE)-0.94
Revenue Per Employee1.33M
Profits Per Employee-1.92M
Employee Count165
Asset Turnover0.30
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BrainAurora Medical Technology Limited is ―. BrainAurora Medical Technology Limited’s PEG ratio is -0.94.
PE Ratio―
PS Ratio30.65
PB Ratio69.27
Price to Fair Value69.27
Price to FCF-32.79
Price to Operating Cash Flow-8.55
PEG Ratio-0.94
Income Statement
In the last 12 months, BrainAurora Medical Technology Limited had revenue of 220.05M and earned -314.86M in profits. Earnings per share was -0.27.
Revenue220.05M
Gross Profit89.45M
Operating Income-290.95M
Pretax Income-316.26M
Net Income-314.86M
EBITDA-276.68M
Earnings Per Share (EPS)-0.27
Cash Flow
In the last 12 months, operating cash flow was -178.03M and capital expenditures -14.31M, giving a free cash flow of -192.34M billion.
Operating Cash Flow-178.03M
Free Cash Flow-192.34M
Free Cash Flow per Share-0.14
Dividends & Yields
BrainAurora Medical Technology Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change-72.33%
50-Day Moving Average7.31
200-Day Moving Average―
Relative Strength Index (RSI)48.32
Average Volume (3m)20.05M
Important Dates
BrainAurora Medical Technology Limited upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 26, 2027
Ex-Dividend Date―
Financial Position
BrainAurora Medical Technology Limited as a current ratio of 1.56, with Debt / Equity ratio of 580.95%
Current Ratio1.56
Quick Ratio1.56
Debt to Market Cap0.08
Net Debt to EBITDA-0.87
Interest Coverage Ratio-12.13
Taxes
In the past 12 months, BrainAurora Medical Technology Limited has paid 100.00K in taxes.
Income Tax100.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BrainAurora Medical Technology Limited EV to EBITDA ratio is -25.25, with an EV/FCF ratio of -33.95.
EV to Sales31.74
EV to EBITDA-25.25
EV to Free Cash Flow-33.95
EV to Operating Cash Flow-39.23
Balance Sheet
BrainAurora Medical Technology Limited has HK$430.36M in cash and marketable securities with HK$565.52M in debt, giving a net cash position of -HK$135.16M billion.
Cash & Marketable SecuritiesHK$430.36M
Total DebtHK$565.52M
Net Cash-HK$135.16M
Net Cash Per Share-HK$0.10
Tangible Book Value Per ShareHK$0.07
Margins
Gross margin is 40.65%, with operating margin of -132.22%, and net profit margin of -143.09%.
Gross Margin40.65%
Operating Margin-132.22%
Pretax Margin-143.72%
Net Profit Margin-143.09%
EBITDA Margin-125.74%
EBIT Margin-132.22%
Analyst Forecast
The average price target for BrainAurora Medical Technology Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―